CRYOGENIC THERAPY TREATMENT LIMITED
Opportunity 64/100 (worth a look), bankability 70/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Resolve: Company dissolved. Company has been dissolved — it no longer legally exists. Any diligence here is historical only. Most likely exit: share sale to pe / searcher (65/100).
Data confidence
Overall: medium (60/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Mixed signal. Worth opening the full target workup before deciding to pursue.
Recent activity
Corporate timeline (33 events)Click to expand
- 2021-10-12📄gazette-dissolved-voluntarygazette · GAZ2(A)
- 2021-10-12🏁Company dissolved
- 2021-07-27📄gazette-notice-voluntarygazette · GAZ1(A)
- 2021-07-19➖GRYCUK, Fiona Mackinnon resignedsecretary
- 2021-07-19📄termination-secretary-company-with-name-termination-dateofficers · TM02
- 2021-07-15📄dissolution-application-strike-off-companydissolution · DS01
- 2021-05-27📄accounts-with-accounts-type-dormantaccounts · AA
- 2021-02-03📄termination-director-company-with-name-termination-dateofficers · TM01
- 2021-01-27➕RUSSELL, Gordon Iain appointeddirector
- 2021-01-27➖LAING, Thomas Fleming resigneddirector
- 2021-01-27📄appoint-person-director-company-with-name-dateofficers · AP01
- 2019-12-13📄accounts-with-accounts-type-dormantaccounts · AA
- 2019-02-26📄accounts-with-accounts-type-dormantaccounts · AA
- 2018-03-09📄accounts-with-accounts-type-dormantaccounts · AA
- 2017-04-06📄accounts-with-accounts-type-dormantaccounts · AA
- 2016-06-15📄annual-return-company-with-made-up-date-full-list-shareholdersannual-return · AR01
- 2016-03-21📄accounts-with-accounts-type-dormantaccounts · AA
- 2015-11-18📄change-person-director-company-with-change-dateofficers · CH01
- 2015-11-18📄change-person-director-company-with-change-dateofficers · CH01
- 2015-11-18📄change-person-secretary-company-with-change-dateofficers · CH03
- 2015-06-15📄annual-return-company-with-made-up-date-full-list-shareholdersannual-return · AR01
- 2015-03-02📄accounts-with-accounts-type-dormantaccounts · AA
- 2014-06-17📄annual-return-company-with-made-up-date-full-list-shareholdersannual-return · AR01
- 2014-03-14📄accounts-with-accounts-type-dormantaccounts · AA
- 2011-03-14➕LAING, Thomas Fleming appointeddirector
- 2005-09-15➕BROOKS, Charles Patrick Evelyn appointeddirector
- 2005-09-15➕DOYLE, Kevin Michael appointeddirector
- 2005-09-15➕GRYCUK, Fiona Mackinnon appointedsecretary
- 2005-09-15➖QUILL SERVE LIMITED resignedcorporate-nominee-secretary
- 2005-09-15➖QUILL FORM LIMITED resignedcorporate-nominee-director
- 2005-06-13🏢Company incorporatedAs CRYOGENIC THERAPY TREATMENT LIMITED
- 2005-06-13➕QUILL SERVE LIMITED appointedcorporate-nominee-secretary
- 2005-06-13➕QUILL FORM LIMITED appointedcorporate-nominee-director
Owner dependency
Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.
- +Long-tenure founder: Senior director has been in place 21 years — deep operational knowledge concentrated in one person.
- +Founder age: Director aged approximately 79 — succession pressure is live.
Succession & seller-readiness
Strong acquirability signals converging. Worth approaching directly — this is how off-market deals start.
- primaryFounder aged 70+: Senior director is approximately 79 years old. Natural succession window is now.
- primary20+ year tenure: Director in role 21 years. Very long tenure is a classic succession signal.
- secondaryStable-but-static management: Company is 21 years old and no new directors in the last 3 years — succession not yet being planned internally.
- supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.
Red flags
1 high ·Company has been dissolved — it no longer legally exists. Any diligence here is historical only.
Evidence: Dissolved on 2021-10-12
Shareholders & ownership
2 active beneficial owners| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Mr Charles Patrick Evelyn Brooks Individual · British · DOB 03/1963 · age 63 | 25–50% | — | 25-50% shares | 13/06/2017 |
Mr Kevin Michael Doyle Individual · British · DOB 05/1947 · age 79 | 25–50% | — | 25-50% shares | 13/06/2017 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Trade services · EH postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| A.J. PURDIE LIMITED→ SC255208 · est 2003 · no financials extracted | — | — | — | — | 22y | — | — |
| A&H CONTRACTORS LIMITED→ SC711911 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| ABURGH SOLUTIONS LIMITED→ SC686800 · est 2021 · no financials extracted | — | — | — | — | 5y | — | — |
| AC LOCKSMITH LTD→ SC530334 · est 2016 · no financials extracted | — | — | — | — | 10y | — | — |
| ACCENTUS EUROPE LIMITED→ SC555131 · est 2017 · no financials extracted | — | — | — | — | 9y | — | — |
| ACCRUAL WORLD LIMITED→ SC868787 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| ADAMANTINE GLOBAL LTD→ SC653253 · est 2020 · no financials extracted | — | — | — | — | 6y | — | — |
| ADVANCED SKINCARE MEDICAL AESTHETICS LTD→ SC716651 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| AEGON SIPP NOMINEE 2 LIMITED→ SC581211 · est 2017 · no financials extracted | — | — | — | — | 8y | — | — |
| AEROFOAM CW LTD→ SC747481 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| AESTHETICALLYUK LIMITED→ SC820530 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| AFRIN Z HAIR LTD→ SC877005 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (0 active · 4 resigned)
Click a director name to see their full track record across all companies.